Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in VIR — Vir Biotechnology, Inc.

CIK 1729829 LONDON, X0
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,536,742
-$4,651,332 QoQ
Shares Held
641,486
-48.6% QoQ
Ownership
0.379%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#38
of 237 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. VIR ranks #65 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 798,715 $240,437,176
2 INSM
INSMED Inc
 1,682,334 $179,370,451
3 REGN
Regeneron Pharmaceuticals, Inc.
 221,607 $138,180,828
4 ROIV
Roivant Sciences Ltd.
 3,454,496 $122,254,613
5 AXSM
Axsome Therapeutics, Inc.
 426,336 $104,354,262
6 APGE
Apogee Therapeutics, Inc.
 659,678 $87,559,060
7 TVTX
Travere Therapeutics, Inc.
 1,443,230 $81,989,896
8 RPRX
Royalty Pharma plc
 1,412,112 $79,177,119

All Filings in VIR

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,536,742 641,486
2026-03-31 $11,188,074 1,248,669
2025-12-31 $500,845 83,059
2025-09-30 $1,554,090 272,170
2025-06-30 $2,217,625 440,005
2025-03-31 $1,883,580 290,676
2024-12-31 $1,137,032 154,909
2024-09-30 $2,682,064 358,086
2024-06-30 $228,418 25,665
2024-03-31 $1,892,719 186,843
2023-12-31 $2,196,993 218,389
2023-09-30 $377,123 40,248
2023-06-30 $845,328 34,461
2022-03-31 $8,459,668 328,914
2020-03-31 $886,462 25,867